Sign in
Neurosciencenpj Parkinson s Disease
Peer-reviewed journal article

Altered cortical network in Parkinson's Disease: the central role of PV interneuron and synaptic remodelling

Antea MinettiiD, Elena MontagniiD, Nicolò MeneghettiiD, Francesca MacchiiD, Éléa Coulomb, Alessandra Martello, Alexia TiberiiD, Simona CapsoniiD, Alberto MazzoniiD, Anna Letizia Allegra MascaroiD, Cristina SpallettiiD

Abstract

Parkinson's disease (PD) is traditionally defined by the progressive degeneration of nigrostriatal dopaminergic neurons; however, accumulating evidence highlights extensive cortical dysfunctions as key contributors to motor and non-motor symptoms. Despite this growing recognition, the precise mechanisms underlying cortical network disruptions and their contribution to PD pathophysiology remain poorly understood, particularly in relation to parvalbumin-positive interneurons (PV-INs) and maladaptive plasticity. Here, we investigate the dysregulation of cortical network homeostasis in PD using a 6-hydroxydopamine (6-OHDA) mouse model, focusing on the progressive disruption of parvalbumin-positive interneuron (PV-IN) connectivity, excitatory/inhibitory balance, and neuroinflammatory responses. Using a multimodal approach integrating longitudinal electrophysiology, wide-field calcium imaging, and histological analyses, we revealed striking alterations in cortical activity and connectivity. Specifically, we observed pathological high-gamma hyperactivity during movement, accompanied by severe disruptions in PV-IN connectivity across motor and somatosensory cortices. Histological analyses further revealed synaptic imbalances and microglial dysregulation, suggesting an extensive cortical response to dopaminergic loss. These findings indicate that PV-IN dysfunction drives cortical maladaptive plasticity, leading to network desynchronization and motor deficits. By reframing PD as a disorder of cortical network homeostasis, this study provides novel mechanistic insights and identifies cortical plasticity as a promising therapeutic target for disease modification.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISBenacom '24Carannante '24Chen '21McLoughlin '25O’Farrell '26Kovaleski '19
76% semantic matchNeuroscience
David Benacom, Camille Chataing, Alain Prochiantz+1 more·bioRxiv·May 31, 2024